Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: A new indication for propranolol treatment

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 4, 2011, Pages

  Hermans, Denise Josephina Johanna ^a   Van Beynum, Ingrid Mathilde ^a   Van Der Vijver, Rozemarijn Junelle ^a   Jan Schultze Kool, Leonardus ^a   De Blaauw, Ivo ^a   Van Der Vleuten, Catharina Joanna Maria ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

blocker; hemangioendothelioma; Kasabach Merritt syndrome; propranolol; vincristine

Indexed keywords

PROPRANOLOL; VINCRISTINE;

ABSENCE OF SIDE EFFECTS; ARTICLE; CASE REPORT; CHILD; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG INDICATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAM; HEMANGIOENDOTHELIOSARCOMA; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; KASABACH MERRITT SYNDROME; LABORATORY TEST; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION;

ADRENERGIC BETA-ANTAGONISTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DISSEMINATED INTRAVASCULAR COAGULATION; DRUG THERAPY, COMBINATION; HEMANGIOENDOTHELIOMA; HEMANGIOMA, CAPILLARY; HEMANGIOMA, CAVERNOUS; HUMANS; INFANT; MALE; PROPRANOLOL; REMISSION INDUCTION; SARCOMA, KAPOSI; SKIN NEOPLASMS; THROMBOCYTOPENIA; VASCULAR NEOPLASMS; VINCRISTINE;

EID: 79955517066     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182152e4e     Document Type: Article

References (20)

1. Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood: an aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol. 1993;17:321-328. (Pubitemid 23096821)
2. Fernandez Y, Bernabeu-Wittel M, Garcia-Morillo JS. Kaposiform hemangioendothelioma. Eur J Intern Med. 2009; 20:106-113.
3. Kasabach HH, Merritt KK. Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child. 1940; 59:1063.
4. Sarkar M, Mulliken JB, Kozakewich HP, et al. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg. 1997;100:1377-1386.
5. Hall GW. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol. 2001;112:851-862. (Pubitemid 32322910)
6. Haisley-Royster C, Enjolras O, Frieden IJ, et al. Kasabachmerritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol. 2002;24:459-462.
7. Sans V, de la Roque ED, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009; 124:e423-e431.
8. Beaubien ER, Ball NJ, Storwick GS. Kaposiform hemangioendothelioma: a locally aggressive vascular tumor. J Am Acad Dermatol. 1998;38:799-802. (Pubitemid 28213689)
9. Fukunaga M, Ushigome S, Ishikawa E. Kaposiform haemangioendothelioma associated with Kasabach-Merritt syndrome. Histopathology. 1996;28:281-284. (Pubitemid 26091916)
10. Vin-Christian K, McCalmont TH, Frieden IJ. Kaposiform hemangioendothelioma: an aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy. Arch Dermatol. 1997;133:1573-1578. (Pubitemid 27525738)
11. Enjolras O, Wassef M, Mazoyer E, et al. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J. Pediatr. 1997;130:631-640. (Pubitemid 27492656)
12. Mulliken JB, Anupindi S, Ezekowitz RA, et al. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises. Case 13-2004. A newborn girl with a large cutaneous lesion, thrombocytopenia, and anemia. N Engl J Med. 2004;350:1764-1775.
13. Drucker AM, Pope E, Mahant S, et al. Vincristine and corticosteroids as first-line treatment of Kasabach-Merritt syndrome in kaposiform hemangioendothelioma. J Cutan Med Surg. 2009;13:155-159.
14. Martinez AE, Robinson MJ, Alexis JB. Kaposiform hemangioendothelioma associated with nonimmune fetal hydrops. Arch Pathol Lab Med. 2004;128:678-681. (Pubitemid 41490430)
15. Blei F, Karp N, Rofsky N, et al. Successful multimodal therapy for kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon: case report and review of the literature. Pediatr Hematol Oncol. 1998;15: 295-305. (Pubitemid 28299828)
16. Hauer J, Graubner U, Konstantopoulos N, et al. Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen. Pediatr Blood Cancer. 2007;49:852-854. (Pubitemid 47519526)
17. Hu B, Lachman R, Phillips J, et al. Kasabach-Merritt syndrome-associated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine, and actinomycin D. J Pediatr Hematol Oncol. 1998;20: 567-569. (Pubitemid 29135826)
18. Mac-Moune LF, To KF, Choi PC, et al. Kaposiform hemangioendothelioma: five patients with cutaneous lesion and long follow-up. Mod Pathol. 2001;14:1087-1092. (Pubitemid 33063200)
19. Chen RL, Chang PY, Hsu YH, et al. Recurrent life-threatening hemothorax in an infant with pleurocutaneous kaposiform hemangio-endothelioma. J Pediatr Hematol Oncol. 2006; 28:630-632.
20. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl JMed. 2008;358:2649-2651. (Pubitemid 351831393)